Open Access
J Oral Med Oral Surg
Volume 26, Number 3, 2020
Article Number 31
Number of page(s) 5
Section Article original / Original article
Published online 16 July 2020
  1. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1–211. [Google Scholar]
  2. Benoliel R, Kahn J, Eliav E. Peripheral painful traumatic trigeminal neuropathies. Oral Dis. 2012;18:317–332. [CrossRef] [PubMed] [Google Scholar]
  3. Polycarpou N, Ng Y-L, Canavan D, Moles DR, Gulabivala K. Prevalence of persistent pain after endodontic treatment and factors affecting its occurrence in cases with complete radiographic healing. Int Endod J. 2005;38:169–178. [Google Scholar]
  4. Baad-Hansen L, Benoliel R. Neuropathic orofacial pain: Facts and fiction. Cephalalgia. 2017;37:670–679. [CrossRef] [PubMed] [Google Scholar]
  5. Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17:1113–e88. [CrossRef] [PubMed] [Google Scholar]
  6. Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpää ML, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(3 Suppl):S3–S14. [Google Scholar]
  7. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287–333. [CrossRef] [PubMed] [Google Scholar]
  8. Haviv Y, Zadik Y, Sharav Y, Benoliel R. Painful traumatic trigeminal neuropathy: an open study on the pharmacotherapeutic response to stepped treatment. J Oral Facial Pain Headache 2014;28:52–60. [Google Scholar]
  9. Loeser JD. Five crises in pain management. Revista de la Sociedad Española del Dolor. 2012;19:111–116. [Google Scholar]
  10. Sessle BJ. The pain crisis: what it is and what can be done. Pain Res Treat. 2012;2012:703947. [PubMed] [Google Scholar]
  11. von Hehn CA, Baron R, Woolf CJ. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron. 2012;73:638–652. [CrossRef] [PubMed] [Google Scholar]
  12. Baron R, Maier C, Attal N, Binder A, Bouhassira D, Cruccu G, et al. Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles. Pain 2017;158:261–272. [CrossRef] [PubMed] [Google Scholar]
  13. Svensson P, Baad-Hansen L, Pigg M, List T, Eliav E, Ettlin D, et al. Guidelines and recommendations for assessment of somatosensory function in oro-facial pain conditions − a taskforce report. J Oral Rehabil. 2011;38:366–394. [CrossRef] [PubMed] [Google Scholar]
  14. Smolensky MH, Portaluppi F, Manfredini R, Hermida RC, Tiseo R, Sackett-Lundeen LL, et al. Diurnal and twenty-four hour patterning of human diseases: acute and chronic common and uncommon medical conditions. Sleep Med Rev. 2015;21:12–22. [CrossRef] [PubMed] [Google Scholar]
  15. Segal JP, Tresidder KA, Bhatt C, Gilron I, Ghasemlou N. Circadian control of pain and neuroinflammation. J Neurosci Res. 2018;96:1002–1020. [PubMed] [Google Scholar]
  16. Kirsch S, Thijssen S, Alarcon Salvador S, Heine GH, van Bentum K, Fliser D, et al. T-cell numbers and antigen-specific T-cell function follow different circadian rhythms. J Clin Immunol. 2012;32:1381–1389. [PubMed] [Google Scholar]
  17. Perry MG, Kirwan JR, Jessop DS, Hunt LP. Overnight variations in cortisol, interleukin 6, tumour necrosis factor alpha and other cytokines in people with rheumatoid arthritis. Ann Rheum Dis. 2009;68:63–68. [CrossRef] [PubMed] [Google Scholar]
  18. Jahanban-Esfahlan R, Mehrzadi S, Reiter RJ, Seidi K, Majidinia M, Baghi HB, et al. Melatonin in regulation of inflammatory pathways in rheumatoid arthritis and osteoarthritis: involvement of circadian clock genes. Br J Pharmacol. 2018;175:3230–3238. [CrossRef] [PubMed] [Google Scholar]
  19. Kouri V-P., Olkkonen J, Kaivosoja E, Ainola M, Juhila J, Hovatta I, et al. Circadian timekeeping is disturbed in rheumatoid arthritis at molecular level. PLoS ONE. 2013;8:e54049. [CrossRef] [PubMed] [Google Scholar]
  20. Odrcich M, Bailey JM, Cahill CM, Gilron I. Chronobiological characteristics of painful diabetic neuropathy and postherpetic neuralgia: diurnal pain variation and effects of analgesic therapy. Pain 2006;120:207–212. [CrossRef] [PubMed] [Google Scholar]
  21. Braud A, Touré B, Agbo-Godeau S, Descroix V, Boucher Y. Characteristics of pain assessed with visual analog scale and questionnaire in burning mouth syndrome patients: a pilot study. J Orofac Pain 2013;27:235–242. [CrossRef] [PubMed] [Google Scholar]
  22. Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003;106:337–345. [CrossRef] [PubMed] [Google Scholar]
  23. Tubert-Jeannin S, Riordan PJ, Morel-Papernot A, Porcheray S, Saby-Collet S. Validation of an oral health quality of life index (GOHAI) in France. Community Dent Oral Epidemiol. 2003;31:275–284. [Google Scholar]
  24. Snaith RP, Zigmond AS. The hospital anxiety and depression scale. Br Med J (Clin Res Ed). 1986;292:344. [Google Scholar]
  25. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 31 2005;352:1324–1334. [CrossRef] [Google Scholar]
  26. Jääskeläinen SK. Is burning mouth syndrome a neuropathic pain condition? Pain 2018;159:610–613. [CrossRef] [PubMed] [Google Scholar]
  27. Gilron I, Ghasemlou N. Chronobiology of chronic pain: focus on diurnal rhythmicity of neuropathic pain. Curr Opin Support Palliat Care. 2014;8:429–436. [CrossRef] [PubMed] [Google Scholar]
  28. Bruguerolle B, Labrecque G. Rhythmic pattern in pain and their chronotherapy. Adv Drug Deliv Rev. 2007;59:883–895. [CrossRef] [Google Scholar]
  29. Petraglia F, Facchinetti F, Parrini D, Micieli G, De Luca S, Genazzani AR. Simultaneous circadian variations of plasma ACTH, beta-lipotropin, beta-endorphin and cortisol. Horm Res. 1983;17:147–152. [CrossRef] [PubMed] [Google Scholar]
  30. Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci. 2007;10:1361–1368. [CrossRef] [PubMed] [Google Scholar]
  31. Melek LN, Devine M, Renton T. The psychosocial impact of orofacial pain in trigeminal neuralgia patients: a systematic review. Int J Oral Maxillofac Surg. 2018;47:869–878. [CrossRef] [PubMed] [Google Scholar]
  32. Barker S, Renton T, Ormrod S. A Qualitative Study to Assess the Impact of Iatrogenic Trigeminal Nerve Injury. J Oral Facial Pain Headache. 2019;33:153–159. [Google Scholar]
  33. Eccleston C, Hearn L, Williams AC de C. Psychological therapies for the management of chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2015;CD011259. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.